Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 9,265 | 4,575 | 3,630 | 3,350 | 6,505 |
| Operating Income | -9,265 | -4,575 | -3,630 | -3,350 | -6,505 |
| Interest Expense | 97 | 99 | 155 | 160 | 51 |
| Other Income | 0 | 0 | 91 | 30 | 0 |
| Pre-tax Income | -9,362 | -4,674 | -3,694 | -3,480 | -6,556 |
| Net Income Continuous | -9,362 | -4,674 | -3,694 | -3,469 | -6,556 |
| Net Income | $-9,362 | $-4,674 | $-3,694 | $-3,469 | $-6,556 |
| EPS Basic Total Ops | -0.46 | -0.45 | 0.34 | -4.50 | -7.85 |
| EPS Basic Continuous Ops | -0.46 | -0.40 | -3.69 | -3.63 | -6.97 |
| EPS Diluted Total Ops | -0.46 | -0.45 | -0.65 | -4.50 | -7.85 |
| EPS Diluted Continuous Ops | -0.46 | -0.40 | -0.49 | -3.63 | -6.97 |
| EBITDA(a) | $-9,227 | $-4,529 | $-3,584 | $-3,311 | $-6,459 |